AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

EyeCity.com, Inc.

$0 -$0.00 (-50.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
455.59K
AVG Volume
2.75M
Trailing/Forward PE
-7.22/-
PEG ratio
-0.07
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
00.250.50.75123 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Revenue (USD) by quarter
PeriodRevenue (USD)
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
23 Q40
23 Q30
Net Income (USD)
-60K-40K-20K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Net Income (USD) by quarter
PeriodNet Income (USD)
25 Q4-53.25K
25 Q3-50.55K
25 Q2-46.05K
25 Q1-50.55K
24 Q4-47.84K
24 Q3-49.83K
24 Q2-46.56K
24 Q1-52.62K
23 Q4-46.05K
23 Q3-49.71K
Operating Income (USD)
-60K-40K-20K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Operating Income (USD) by quarter
PeriodOperating Income (USD)
25 Q4-53.25K
25 Q3-50.55K
25 Q2-46.05K
25 Q1-50.55K
24 Q4-47.84K
24 Q3-49.83K
24 Q2-46.56K
24 Q1-52.62K
23 Q4-46.05K
23 Q3-49.71K
EBITDA (USD)
-60K-40K-20K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY EBITDA (USD) by quarter
PeriodEBITDA (USD)
25 Q4-53.25K
25 Q3-50.55K
25 Q2-46.05K
25 Q1-50.55K
24 Q4-47.84K
24 Q3-49.83K
24 Q2-46.56K
24 Q1-52.62K
23 Q4-2.24K
23 Q3-49.71K
Cash Flows (USD)
-6M-4M-2M02M4M00 Q401 Q101 Q201 Q301 Q422 Q322 Q423 Q123 Q223 Q3
ICTY Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q30
23 Q2-1.25M
23 Q11.25M
22 Q41
22 Q30
01 Q42.76M
01 Q3-22.3K
01 Q2-57.08K
01 Q1-4.42M
00 Q4-469.43K
EPS (USD)
-0-0-0-0-023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY EPS (USD) by quarter
PeriodEPS (USD)
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
23 Q40
23 Q3-0
Expenses (USD)
020K40K60KR&DSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q20
23 Q10
22 Q40
22 Q30
01 Q40
01 Q30
01 Q20
01 Q10
00 Q42.87K
25 Q453.25K
25 Q350.55K
25 Q246.05K
25 Q150.55K
24 Q447.84K
24 Q349.83K
24 Q246.56K
24 Q152.62K
23 Q446.05K
23 Q319.71K
Cash & Debt (USD)
0200K400K600KCashLong Term DebtShort Term Debt22 Q322 Q423 Q123 Q223 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
Debt ratios
-4-202422 Q322 Q423 Q123 Q223 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Debt ratios by quarter
PeriodDebt ratios
25 Q4-2.13
25 Q3-2.14
25 Q2-2.12
25 Q1-2.11
24 Q4-0.65
23 Q3-0.52
23 Q2-0.67
23 Q12.45
22 Q4-1.73
22 Q3-0.43
Margins
-20%0%20%40%60%00 Q100 Q200 Q300 Q401 Q101 Q201 Q301 Q4
ICTY Margins by quarter
PeriodMargins
01 Q450.09%
01 Q351.35%
01 Q245.26%
01 Q158.2%
00 Q4-0.55%
00 Q335.98%
00 Q229.56%
00 Q147.48%
Return on Capital
-20%-10%0%10%20%22 Q322 Q423 Q123 Q223 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Return on Capital by quarter
PeriodReturn on Capital
25 Q49.98%
25 Q310.52%
25 Q210.71%
25 Q13.65%
24 Q43.59%
23 Q34.56%
23 Q24.47%
23 Q1-19.36%
22 Q44.88%
22 Q35.52%
Shares Outstanding
02B4B6B8B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Shares Outstanding by quarter
PeriodShares Outstanding
25 Q47.23B
25 Q37.23B
25 Q27.23B
25 Q17.23B
24 Q47.23B
24 Q37.23B
24 Q27.23B
24 Q17.23B
23 Q47.23B
23 Q37.23B
Book Value Per Share (USD)
-0-00022 Q322 Q423 Q123 Q223 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
23 Q3-0
23 Q2-0
23 Q10
22 Q4-0
22 Q3-0
Total Assets (USD)
0500K1M1.5M22 Q322 Q423 Q123 Q223 Q324 Q425 Q125 Q225 Q325 Q4
ICTY Total Assets (USD) by quarter
PeriodTotal Assets (USD)
25 Q4848K
25 Q3848K
25 Q2848K
25 Q1348K
24 Q468K
23 Q30
23 Q20
23 Q11.25M
22 Q40
22 Q30
Free Cash Flow Yield
-8000%-6000%-4000%-2000%0%2000%med -673.18%Aug 01Oct 01Dec 01Mar 02Nov 23Jan 24Mar 24
ICTY Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Mar 240%
Mar 240%
Mar 240%
Mar 240%
Mar 240%
Feb 240%
Feb 240%
Feb 240%
Feb 240%
Jan 240%
Jan 240%
Jan 240%
Jan 240%
Dec 230%
Dec 230%
Dec 230%
Dec 230%
Dec 230%
Nov 230%
Nov 230%
Nov 230%
Nov 230%
Oct 230%
Oct 230%
Oct 230%
Oct 230%
Sep 230%
Mar 02-535.48%
Mar 02-523.58%
Mar 02-604.13%
Mar 02-841.47%
Mar 02-942.45%
Feb 02-906.2%
Feb 02-906.2%
Feb 02-906.2%
Feb 02-1121.96%
Jan 02-673.18%
Jan 02-620.03%
Jan 02-620.03%
Jan 02-673.18%
Dec 01-4428.3%
Dec 01-4428.3%
Dec 01-4428.3%
Dec 01-5166.35%
Nov 01-4428.3%
Nov 01-5166.35%
Nov 01-7380.5%
Nov 01-6199.62%
Nov 01-5166.35%
Oct 01-5166.35%
Oct 01-5166.35%
Oct 01-5166.35%
Oct 01-5166.35%
Sep 01-4428.3%
Sep 01-1368.11%
Sep 01-1197.09%
Sep 01-1197.09%
Aug 01-1064.08%
Aug 01-1064.08%
Aug 01-1197.09%
Aug 01-1368.11%
Aug 01-1368.11%
Jul 01-1197.09%
Jul 01-1064.08%
Jul 01-1064.08%
Jul 01-1064.08%
Jun 01-1064.08%
Price to Sales
0200400600800med 1.46Aug 01Nov 01Jan 02Jul 21Oct 21Dec 21Mar 22
ICTY Price to Sales by quarter
PeriodPrice to Sales
Mar 22211.85
Mar 22211.85
Mar 22181.59
Mar 22211.85
Feb 22196.72
Feb 22181.59
Feb 22272.38
Feb 22272.38
Jan 22348.04
Jan 22544.76
Jan 22575.02
Jan 22575.02
Dec 21696.08
Dec 21216.31
Dec 21257.23
Dec 21222.15
Dec 21245.54
Nov 21280.61
Nov 21257.23
Nov 21280.61
Nov 21245.54
Oct 21280.61
Oct 21315.69
Oct 21245.54
Oct 21163.69
Oct 21157.84
Sep 21107.59
Sep 2193.25
Sep 21107.59
Sep 2186.07
Aug 2178.9
Aug 2178.9
Aug 2193.25
Aug 2193.25
Jul 2196.83
Jul 2193.25
Jul 2193.25
Jul 2193.25
Jul 21107.59
Mar 021.43
Mar 021.46
Mar 021.27
Mar 020.91
Mar 020.81
Feb 020.85
Feb 020.85
Feb 020.85
Feb 020.68
Jan 021.14
Jan 021.24
Jan 021.24
Jan 021.14
Dec 010.1
Dec 010.1
Dec 010.1
Dec 010.09
Nov 010.1
Nov 010.09
Nov 010.06
Nov 010.07
Nov 010.09
Oct 010.09
Oct 010.09
Oct 010.09
Oct 010.09
Sep 010.1
Sep 010.23
Sep 010.26
Sep 010.26
Aug 010.29
Aug 010.29
Aug 010.26
Aug 010.23
Aug 010.23
Jul 010.26
Jul 010.29
Jul 010.29
Jul 010.29
Jun 010.29
EV/EBITDA
406080100med 45.32Jun 23Jul 23Jul 23Aug 23Aug 23Sep 23Sep 23
ICTY EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2345.32
Sep 2345.32
Sep 2345.32
Sep 2388.2
Aug 2388.2
Aug 2345.32
Aug 2388.2
Aug 2388.2
Jul 2345.32
Jul 2345.32
Jul 2388.2
Jul 2345.32
Jun 2345.32
Price/Operating Cashflow
6000008000001000000120000014000001600000med 1446593.09Oct 23Nov 23Dec 23Jan 24Feb 24Mar 24Mar 24
ICTY Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Mar 241084944.82
Mar 241446593.09
Mar 241446593.09
Mar 241446593.09
Mar 241446593.09
Feb 241446593.09
Feb 241446593.09
Feb 241446593.09
Feb 241446593.09
Jan 241446593.09
Jan 241446593.09
Jan 241446593.09
Jan 241446593.09
Dec 23723296.54
Dec 231446593.09
Dec 23723296.54
Dec 231446593.09
Dec 231446593.09
Nov 231446593.09
Nov 231446593.09
Nov 231446593.09
Nov 231446593.09
Oct 231446593.09
Oct 231446593.09
Oct 231446593.09
Oct 23723296.54
Sep 231084944.82
Price to Book
02468med 3.08Jul 00Sep 00Nov 00Jan 01Mar 01Jul 23Sep 23
ICTY Price to Book by quarter
PeriodPrice to Book
Sep 233.08
Sep 233.08
Sep 233.08
Sep 236.17
Aug 236.17
Aug 233.08
Aug 236.17
Aug 236.17
Jul 233.08
Jul 233.08
Jul 236.17
Jul 233.08
Jun 233.08
Mar 010.77
Mar 010.93
Mar 011.24
Mar 011.08
Mar 011.24
Feb 011.7
Feb 011.93
Feb 012.16
Feb 012.32
Jan 012.47
Jan 012.01
Jan 012.16
Jan 012.32
Dec 001.55
Dec 001.05
Dec 001.79
Dec 001.84
Dec 002.87
Nov 003.28
Nov 003.69
Nov 004.31
Nov 003.69
Oct 003.69
Oct 003.89
Oct 004.1
Oct 004.93
Sep 005.13
Sep 003.47
Sep 004.83
Sep 003.65
Sep 003.22
Aug 002.6
Aug 003.97
Aug 002.02
Aug 002.11
Jul 002.11
Jul 002.72
Jul 003.21
Jul 002.97
Jun 003.22
EyeCity.com, Inc.
ICTY
Stockpicker

Video analysis: ICTY

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.